What's new

What's new

Human medicines European public assessment report (EPAR): Xyrem, sodium oxybate, Date of authorisation: 13/10/2005, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Xyrem, sodium oxybate, Date of authorisation: 13/10/2005, Revision: 37, Status: Authorised

12 May 2025

Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 2, Status: Authorised

12 May 2025

EMA workshop on primary efficacy endpoints for antivirals and mAbs intended for the treatment of COVID-19 and Influenza, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 June 2025, 13:00 (CEST) to 6 June 2025, 17:00 (CEST)

EMA workshop on primary efficacy endpoints for antivirals and mAbs intended for the treatment of COVID-19 and Influenza, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 June 2025, 13:00 (CEST) to 6 June 2025, 17:00 (CEST)

12 May 2025

Minutes of the HMPC meeting 17-19 March 2025

Minutes of the HMPC meeting 17-19 March 2025

12 May 2025

EMA/FVE info session for veterinary practitioners : Understanding the first report of sales and use of antimicrobials in animals, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2024, 15:30 (CEST) to 3 June 2024, 16:30 (CEST)

EMA/FVE info session for veterinary practitioners : Understanding the first report of sales and use of antimicrobials in animals, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2024, 15:30 (CEST) to 3 June 2024, 16:30 (CEST)

12 May 2025

PSUSA/00010571/202407

PSUSA/00010571/202407

12 May 2025

PSUSA/00003143/202409

PSUSA/00003143/202409

12 May 2025

PSUSA/00002643/202408

PSUSA/00002643/202408

12 May 2025

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 15, Status: Authorised

12 May 2025

PSUSA/00010072/202409

PSUSA/00010072/202409

12 May 2025